16.81
price up icon4.09%   0.66
after-market 시간 외 거래: 16.81
loading
전일 마감가:
$16.15
열려 있는:
$16.16
하루 거래량:
1.13M
Relative Volume:
0.65
시가총액:
$2.86B
수익:
-
순이익/손실:
$-382.71M
주가수익비율:
-6.416
EPS:
-2.62
순현금흐름:
$-325.64M
1주 성능:
+6.73%
1개월 성능:
+9.09%
6개월 성능:
-33.27%
1년 성능:
-36.61%
1일 변동 폭
Value
$16.00
$17.06
1주일 범위
Value
$15.50
$17.06
52주 변동 폭
Value
$12.72
$34.47

Immunovant Inc Stock (IMVT) Company Profile

Name
명칭
Immunovant Inc
Name
전화
917-580-3099
Name
주소
320 WEST 37TH STREET, NEW YORK, NY
Name
직원
362
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
IMVT's Discussions on Twitter

IMVT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IMVT
Immunovant Inc
16.81 2.86B 0 -382.71M -325.64M -2.62
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Immunovant Inc Stock (IMVT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-03 개시 Jefferies Hold
2025-01-03 다운그레이드 Wolfe Research Outperform → Peer Perform
2024-10-10 재개 Raymond James Outperform
2024-10-09 재확인 Oppenheimer Outperform
2024-03-28 개시 Oppenheimer Outperform
2024-03-13 개시 Goldman Buy
2024-02-20 개시 JP Morgan Overweight
2024-02-15 개시 Wolfe Research Outperform
2023-12-12 개시 Deutsche Bank Buy
2023-10-13 업그레이드 UBS Neutral → Buy
2023-09-26 업그레이드 Raymond James Mkt Perform → Outperform
2023-05-01 개시 BofA Securities Buy
2023-04-25 개시 Citigroup Buy
2023-03-31 개시 Piper Sandler Overweight
2023-03-30 개시 Stifel Buy
2023-02-15 개시 Cantor Fitzgerald Overweight
2023-02-13 업그레이드 Guggenheim Neutral → Buy
2023-01-03 업그레이드 Wells Fargo Equal Weight → Overweight
2022-09-26 다운그레이드 UBS Buy → Neutral
2021-12-08 개시 Wells Fargo Equal Weight
2021-08-03 다운그레이드 Robert W. Baird Outperform → Neutral
2021-08-02 다운그레이드 Credit Suisse Neutral → Underperform
2021-06-01 다운그레이드 Guggenheim Buy → Neutral
2021-06-01 다운그레이드 Stifel Buy → Hold
2020-10-28 개시 UBS Buy
2020-10-12 개시 Guggenheim Buy
2020-10-08 개시 Stifel Buy
2020-10-02 개시 Credit Suisse Outperform
2020-08-26 재확인 H.C. Wainwright Buy
2020-08-25 개시 Raymond James Outperform
2020-07-29 개시 H.C. Wainwright Buy
2020-02-24 개시 SVB Leerink Outperform
모두보기

Immunovant Inc 주식(IMVT)의 최신 뉴스

pulisher
Jun 17, 2025

GAMMA Investing LLC Buys 5,229 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Jun 17, 2025
pulisher
Jun 15, 2025

Learn to Evaluate (IMVT) using the Charts - news.stocktradersdaily.com

Jun 15, 2025
pulisher
Jun 15, 2025

Immunovant, Inc. (NASDAQ:IMVT) Receives $38.33 Consensus Target Price from Brokerages - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Immunovant: Navigating The Complexities Of The FcRn Landscape (Downgrade) - Seeking Alpha

Jun 13, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Forecasts Immunovant FY2027 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 08, 2025

Immunovant, Inc. (NASDAQ:IMVT) Shares Sold by Wellington Management Group LLP - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Two Sigma Advisers LP Buys New Position in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Ameriprise Financial Inc. Makes New Investment in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Jun 07, 2025
pulisher
Jun 04, 2025

Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX), Dexcom (DXCM) and Immunovant (IMVT) - The Globe and Mail

Jun 04, 2025
pulisher
Jun 03, 2025

Immunovant (IMVT) Upgraded to Buy: What Does It Mean for the Stock? - MSN

Jun 03, 2025
pulisher
Jun 02, 2025

Long Term Trading Analysis for (IMVT) - news.stocktradersdaily.com

Jun 02, 2025
pulisher
Jun 02, 2025

Leerink Partnrs Estimates Immunovant FY2030 Earnings - Defense World

Jun 02, 2025
pulisher
May 31, 2025

IMVT Q4 Loss Narrower Than Expected, Stock Up, Pipeline in Focus - MSN

May 31, 2025
pulisher
May 30, 2025

Immunovant price target lowered to $35 from $51 at H.C. Wainwright - TipRanks

May 30, 2025
pulisher
May 30, 2025

Immunovant’s Promising Future: Buy Rating Backed by Strategic Advancements and Strong Cash Position - TipRanks

May 30, 2025
pulisher
May 30, 2025

Immunovant Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 30, 2025
pulisher
May 30, 2025

H.C. Wainwright Adjusts Price Target for Immunovant (IMVT) Amid Future Prospects | IMVT Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Immunovant Insiders Sell US$5.9m Of Stock, Possibly Signalling Caution - simplywall.st

May 30, 2025
pulisher
May 30, 2025

Immunovant (NASDAQ:IMVT) Shares Gap Up After Better-Than-Expected Earnings - Defense World

May 30, 2025
pulisher
May 30, 2025

Immunovant, Inc. Reports Strategic Progress and Financial Results - TipRanks

May 30, 2025
pulisher
May 29, 2025

IMVT INVESTIGATION ALERT: Investigation Launched into Private Placement Transaction by Immunovant, Inc. and Attorneys Encourage Investors to Contact Law Firm - The Malaysian Reserve

May 29, 2025
pulisher
May 29, 2025

Immunovant, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Immunovant Stock Rises On Narrower-Than-Expected Q1 Loss: Retail’s Still On The Fence By Stocktwits - Investing.com India

May 29, 2025
pulisher
May 29, 2025

Immunovant Stock Rises On Narrower-Than-Expected Q1 Loss: Retail’s Still On The Fence - MSN

May 29, 2025
pulisher
May 29, 2025

Immunovant, Inc. SEC 10-K Report - TradingView

May 29, 2025
pulisher
May 29, 2025

Immunovant (IMVT) Secures Strong Financial Position with $714 Million in Cash | IMVT Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunovant's Fiscal Q4 Net Loss Widens - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Earnings Flash (IMVT) IMMUNOVANT INC. Reports Q4 Loss $0.64 Per Share, vs. FactSet Est of $-0.71 - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Immunovant's Clinical Trials Show 74% Success in Myasthenia Gravis, Advancing 6 Disease Programs - Stock Titan

May 29, 2025
pulisher
May 28, 2025

Immunovant (IMVT) to Release Earnings on Wednesday - Defense World

May 28, 2025
pulisher
May 25, 2025

Bank of America Corp DE Buys 114,511 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World

May 25, 2025
pulisher
May 23, 2025

(IMVT) Trading Advice - news.stocktradersdaily.com

May 23, 2025
pulisher
May 21, 2025

IMVT INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into a Private Placement Transaction by Immunovant, Inc. and Encourages Investors to Contact the Firm - Business Wire

May 21, 2025
pulisher
May 21, 2025

Brokerages Set Immunovant, Inc. (NASDAQ:IMVT) Target Price at $38.33 - Defense World

May 21, 2025
pulisher
May 16, 2025

Immunovant, Inc. (NASDAQ:IMVT) Shares Bought by Northern Trust Corp - Defense World

May 16, 2025
pulisher
May 15, 2025

Is Immunovant, Inc. (IMVT) The Most Undervalued Stock With Smart Money Ratings? - Insider Monkey

May 15, 2025
pulisher
May 15, 2025

The Manufacturers Life Insurance Company Has $889,000 Stock Position in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

May 15, 2025
pulisher
May 14, 2025

Transcript : Immunovant, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 04 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Smart Money Ratings For 20 Most Undervalued Stocks - Insider Monkey

May 14, 2025
pulisher
May 12, 2025

Immunovant Inc (NASDAQ: IMVT) Is The Among Hot Stock Right Now - Stocksregister

May 12, 2025
pulisher
May 11, 2025

Dimensional Fund Advisors LP Sells 58,463 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World

May 11, 2025
pulisher
May 09, 2025

Is Immunovant, Inc. (IMVT) The Best Stock That Will Bounce Back? - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

Raymond James Financial Inc. Buys Shares of 20,382 Immunovant, Inc. (NASDAQ:IMVT) - Defense World

May 09, 2025
pulisher
May 08, 2025

11 Stocks That Will Bounce Back According to Analysts - Insider Monkey

May 08, 2025
pulisher
May 06, 2025

Investor’s Delight: Immunovant Inc (IMVT) Closes Weak at 15.22, Down -3.67 - DWinneX

May 06, 2025
pulisher
May 02, 2025

Ins & Outs: Biopharma players shuffle c-suite ranks - BioProcess International

May 02, 2025
pulisher
May 02, 2025

(IMVT) Investment Analysis - news.stocktradersdaily.com

May 02, 2025
pulisher
May 02, 2025

Immunovant, Inc. (NASDAQ:IMVT) Shares Acquired by Wells Fargo & Company MN - Defense World

May 02, 2025
pulisher
May 01, 2025

A company insider recently sold 1,925 shares of Immunovant Inc [IMVT]. Should You Sale? - knoxdaily.com

May 01, 2025
pulisher
May 01, 2025

IMVT’s Stock Market Adventure: -34.80% YTD Growth Amidst Volatility - investchronicle.com

May 01, 2025
pulisher
May 01, 2025

Thyroid Eye Disease Pipeline 2025: MOA, ROA, and Clinical Trial - openPR.com

May 01, 2025

Immunovant Inc (IMVT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):